share_log

Pineapple Financial And 1 Other Stock Under $1 Insiders Are Buying

Pineapple Financial And 1 Other Stock Under $1 Insiders Are Buying

菠蘿金融和另外1只股票低於1美元,內部人正在購買
Benzinga ·  08/05 21:13

The Dow Jones index closed lower by over 600 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

道瓊斯指數週五下跌超過600點。當內部人士購買或出售股票時,這表明他們對公司前景的信心或擔憂。對於有興趣投資或交易低價股票的投資者和交易者,可以將此視爲其整體投資或交易決策的因素。

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

以下是幾個近期關於低價股的值得關注的內部交易。了解更多,請查看Benzinga內幕交易平台。

Pineapple Financial

菠蘿融資

  • The Trade: Pineapple Financial Inc. (NYSE:PAPL) CSO Christa Lillian Mitchell bought a total of 2,000 shares at an average price of $1.02. To acquire these shares, it cost around $2,040.
  • What's Happening: On July 16, Pineapple Financial posted a wider-than-expected quarterly loss.
  • What Pineapple Financial Does: Pineapple Financial Inc is a Canada-based mortgage technology and brokerage company that provides mortgage brokerage services and technology solutions to Canadian mortgage agents, brokers, sub-brokers, brokerages, and consumers.
  • 交易:Pineapple Financial Inc.(紐交所:PAPL)首席戰略官Christa Lillian Mitchell以平均價1.02美元購買了總共2,000股。要取得這些股票,花費了約2,040美元。
  • 最新消息:7月16日,Pineapple Financial公佈了一季度的虧損超出預期。
  • Pineapple Financial Inc是一家加拿大抵押貸款科技和券商公司,爲加拿大抵押貸款經紀人、券商、子券商、券商和消費者提供抵押貸款經紀服務和技術解決方案。

Vivos

Vivos

  • The Trade: Vivos Inc. (OTC:RDGL) President and CEO Michael K Korenko acquired a total of 50,000 shares at an average price of $0.09. To acquire these shares, it cost around $4,360.
  • What's Happening: On June 28, Vivos submitted the application to the FDA for authority to initiate human clinical trials.
  • What Vivos Does: Vivos Inc is a radiation oncology medical device company
  • 交易:Vivos Inc.(場外交易:RDGL)總裁兼首席執行官Michael k Korenko以平均價0.09美元購買了總共50,000股。要取得這些股票,花費了約4,360美元。
  • 正在發生什麼事:6月28日,Vivos提交了向FDA申請,以獲得啓動人類臨床試驗的授權。
  • Vivos Inc.是一家放射治療醫療器械公司。
  • Wall Street's Most Accurate Analysts' Views On 3 Materials Stocks Delivering High-Dividend Yields
  • 華爾街最準確的分析師對3只提供高股息收益的材料股的觀點

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論